Compositions and methods for treating thrombocytopenia

Details for Australian Patent Application No. 2006313491 (hide)

Owner Astellas Pharma Inc.

Inventors Suzuki, Ken-Ichi; Sugasawa, Keizo

Agent Wrays

Pub. Number AU-B-2006313491

PCT Pub. Number WO2007/054783

Priority 60/734,426 08.11.05 US

Filing date 7 November 2006

Wipo publication date 18 May 2007

Acceptance publication date 6 January 2011

International Classifications

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 7/00 (2006.01) Drugs for disorders of the blood or the extracellular fluid

Event Publications

29 May 2008 PCT application entered the National Phase

  PCT publication WO2007/054783 Priority application(s): WO2007/054783

6 January 2011 Application Accepted

  Published as AU-B-2006313491

12 May 2011 Standard Patent Sealed

31 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006313493-Mu-conotoxin peptides and use thereof as a local anesthetic

2006313490-Stabilized lanthanum carbonate compositions